Stock Analysis

Endava First Quarter 2025 Earnings: EPS Misses Expectations

NYSE:DAVA
Source: Shutterstock

Endava (NYSE:DAVA) First Quarter 2025 Results

Key Financial Results

  • Revenue: UK£195.1m (up 3.5% from 1Q 2024).
  • Net income: UK£2.25m (down 82% from 1Q 2024).
  • Profit margin: 1.2% (down from 6.6% in 1Q 2024).
  • EPS: UK£0.038 (down from UK£0.21 in 1Q 2024).
earnings-and-revenue-growth
NYSE:DAVA Earnings and Revenue Growth November 14th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Endava EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 15%.

Looking ahead, revenue is forecast to grow 9.8% p.a. on average during the next 3 years, compared to a 9.6% growth forecast for the IT industry in the US.

Performance of the American IT industry.

The company's shares are up 13% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 2 warning signs for Endava you should know about.

Valuation is complex, but we're here to simplify it.

Discover if Endava might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.